BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, March 14, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 1999

View Archived Issues

Favorable data presented for PEGASYS in HCV therapy

Read More

Glaxo Wellcome launches first drug to treat PPH in Japan

Read More

ImClone highlights Q1 1999 progress with cancer products

Read More

Therapeutic Antibodies reports advances in product development in Q1 1999

Read More

Progress in key development programs reported by Cantab

Read More

Novel epoxysuccinamide derivatives for bone diseases/arthritis developed at Nippon Chemiphar

Read More

Hokuriku Seiyaku claims new thiourea antibacterial agents

Read More

Muscarinic antagonists from Tokyo Tanabe particularly useful for respiratory disorders

Read More

Merck presents new 8a-azalides and their use in the treatment of bacterial infections

Read More

BASF describes new, selective ECE inhibitors

Read More

K1-5 is a more potent angiogenesis inhibitor than angiostatin

Read More

Tetrahydrofurans as 5-HT2 receptor antagonists: synthesis and preliminary pharmacological evaluation

Read More

Novel series from Dr. Reddy for diabetes, hyperlipidemia, etc.

Read More

Merck closes in on oral oxytocin antagonist for use in preterm labor

Read More

Corixa, Zambon collaborate to develop lung cancer immunotherapeutic vaccines

Read More

Addition of BTI-322 to tacrolimus immunosuppression decreases incidence of transplant rejection

Read More

L-770644: potent and selective human beta3-adrenoceptor agonist with good oral bioavailability

Read More

Transplantation news: neutrophil NADPH oxidase inhibitor improves functioning of preserved hearts

Read More

MDX-447 shows promising biological activity in phase I/II trial, results reported at ASCO meeting

Read More

SkyePharma announces U.S. launch of DepoCyt

Read More

Axcan's Protectaid contraceptive sponge approved in Italy

Read More

Abgenix MAb shows promise in GVHD following stem cell transplantation and heads for pivotal trials

Read More

Alteon to seek new partner for continued pimagedine development

Read More

C225 demonstrates high efficacy and good tolerance in two types of carcinomas

Read More

Cortex receives SBIR grant for new stroke therapy

Read More

FDA approves Vioxx for osteoarthritis, acute pain and menstrual pain

Read More

Adenosine A1 antagonist prevents ischemia-reperfusion injury in the liver

Read More

Chinese Kampo medicine is effective and safe in the treatment of bowel obstruction

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

    BioWorld Science
    Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing